Your browser doesn't support javascript.
loading
A Phase Ib Study of Alpelisib (BYL719), a PI3Kα-Specific Inhibitor, with Letrozole in ER+/HER2- Metastatic Breast Cancer.
Mayer, Ingrid A; Abramson, Vandana G; Formisano, Luigi; Balko, Justin M; Estrada, Mónica V; Sanders, Melinda E; Juric, Dejan; Solit, David; Berger, Michael F; Won, Helen H; Li, Yisheng; Cantley, Lewis C; Winer, Eric; Arteaga, Carlos L.
  • Mayer IA; Vanderbilt-Ingram Cancer Center (VICC), Vanderbilt University, Nashville, Tennessee. ingrid.mayer@vanderbilt.edu carlos.arteaga@vanderbilt.edu.
  • Abramson VG; Vanderbilt-Ingram Cancer Center (VICC), Vanderbilt University, Nashville, Tennessee.
  • Formisano L; Vanderbilt-Ingram Cancer Center (VICC), Vanderbilt University, Nashville, Tennessee.
  • Balko JM; Vanderbilt-Ingram Cancer Center (VICC), Vanderbilt University, Nashville, Tennessee.
  • Estrada MV; Vanderbilt-Ingram Cancer Center (VICC), Vanderbilt University, Nashville, Tennessee.
  • Sanders ME; Vanderbilt-Ingram Cancer Center (VICC), Vanderbilt University, Nashville, Tennessee.
  • Juric D; Massachusetts General Hospital (MGH), Boston, Massachusetts.
  • Solit D; Memorial Sloan-Kettering Cancer Center (MSKCC), New York, New York.
  • Berger MF; Memorial Sloan-Kettering Cancer Center (MSKCC), New York, New York.
  • Won HH; Memorial Sloan-Kettering Cancer Center (MSKCC), New York, New York.
  • Li Y; The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Cantley LC; Weill Cornell Medical College, New York, New York.
  • Winer E; Dana-Farber Cancer Institute (DFCI), Boston, Massachusetts.
  • Arteaga CL; Vanderbilt-Ingram Cancer Center (VICC), Vanderbilt University, Nashville, Tennessee. ingrid.mayer@vanderbilt.edu carlos.arteaga@vanderbilt.edu.
Clin Cancer Res ; 23(1): 26-34, 2017 Jan 01.
Article en En | MEDLINE | ID: mdl-27126994
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Receptores de Estrógenos / Receptor ErbB-2 / Inhibidores de las Quinasa Fosfoinosítidos-3 Tipo de estudio: Clinical_trials Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Receptores de Estrógenos / Receptor ErbB-2 / Inhibidores de las Quinasa Fosfoinosítidos-3 Tipo de estudio: Clinical_trials Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Año: 2017 Tipo del documento: Article